LIC sector's great consolidation

LICs appeal to Australian investors wanting reliable fully franked dividends. But many traded at a discount to net tangible assets which has prompted widespread rationalisation.

Tony Boyd

LIC sector's great consolidation

September 29, 2020
LICs appeal to Australian investors wanting reliable fully franked dividends. But many traded at a discount to net tangible assets which has prompted widespread rationalisation.
Read Transcript

LICs appeal to Australian investors wanting reliable fully franked dividends. But many traded at a discount to net tangible assets which has prompted widespread rationalisation.

The $50 billion listed investment company sector is a hotbed of consolidation as one big player and smaller groups of shareholder activists crank up the pressure on boards to close the widespread discounts to net tangible assets.

Proof that the strong are getting stronger and the weak disappearing came on Monday when the Australian Leaders Fund said it would allow shareholders to switch to an unlisted unit trust offering redemptions at NTA and entities managed by Wilson Asset Management made a takeover bid for the Contango Income Generator.

Industry veterans say the level of activity around the efforts to close the discounts to NTA are the most intense the market has seen since a wave of consolidation occurred in 2003 and 2004.

Discounts to NTA have been a feature of the LIC sector for decades and many different methods have been used to close the discount. The discounts can blow out to 25 per cent or higher. Some LICs have had their share prices stuck at 10 per cent discounts to NTA for years.

This rightly causes angst among shareholders, especially those who joined an LIC at the time of its float and then watched their investment sink in value on the sharemarket. Their plight is made less palatable when they see other LICs trading at premiums to NTA.

It may not be fair but poor performance in the sharemarket often has nothing to do with the movement in NTA, which can rise because of good funds management decisions and then not be reflected in the share price.

It would seem LIC investors are great believers in this structure for getting access to franked dividends. Chanticleer understands that up to a third of the individuals on the share registers of some prominent LICs are also owners of rival LICs. This plays into the hands of consolidators like Geoff Wilson at WAM.

 

Shareholder action

LICs trading at a premium to NTA include Australian Foundation Investment Company, Argo Investments and five of the six LICs in the WAM stable. They owe their premium status to their consistent and growing dividend payment policies.

Poor performers in the sector are increasingly finding themselves the subject of corporate action or agitation by shareholders concerned about entrenched practices that foster lack of transparency and accountability.

Two veterans of the finance sector, Malcolm McComas and Rob Ferguson, dipped their toes in the LIC consolidation pool this year with a successful agitation campaign against the board of ALF for its discount to NTA.

They claimed the manager of ALF, Justin Braitling's Watermark Funds Management, was responsible for poor sharemarket performance and action was needed. Their attack on ALF's failure to address its discount to NTA included criticism of Wilson, who is the most active player in terms of rationalising LICs.

In a letter to ALF shareholders, McComas and Ferguson said "the board of ALF has had a wake-up call on its terrible past governance and finally decided to appoint an independent board committee composed of directors John Abernethy and Julian Gosse to consider appropriate capital management strategies to recommend to all shareholders".

"The appointment of this committee in response to our agitation is highly significant," Ferguson and McComas said.

"First it is clear recognition that our chairman Justin Braitling and his fellow director Geoff Wilson are not independent and should absent themselves from any board matters where they have a conflict of interest.

"It is likely that any “capital management strategies” will reduce the size of the company materially and therefore materially reduce the fees paid to Justin Braitling’s company Watermark Funds Management. WFM shares such fees with an entity associated with Geoff Wilson and thus their conflicts of interest arise and mean they cannot vote on such matters."

 

Experimental techniques

Wilson tells Chanticleer the ALF funds management contract is with Watermark and not him. Also, he questioned the corporate performances of McComas and Ferguson.

Ferguson says Abernethy did a good job negotiating a termination of Watermark's funds management agreement at a price of $2.5 million or 1.25 per cent of NTA. This contract had another seven years to run.

The nearest comparable deal was the termination of the Ellerston Capital funds management contract with Ellerston Global Investments.

McComas says the ALF solution to its discount to NTA problem is not fair to shareholders because if you redeem your shares within the first year there is a fee of 2 per cent.

Abernethy says contractual agreements cannot be unwound easily. He says it is possible shareholders who stay with the ALF entity for more than a year could achieve an internal rate of return of 7 per cent assuming redemption after the period when the 2 per cent fee requirement has expired.

Wilson is being highly proactive in reduced discounts to NTA with other LICs. The WAM Capital bid for Contango Income Generator is a share swap deal that values each share at a 74¢, which is either equal to NTA or a premium.

At the same time, Wilson has a takeover bid for the Concentrated Leaders Fund which involves a WAM Capital share swap that values each share at about $1.18, a premium to NTA.

Other LICs trading at a discount are experimenting with new techniques for closing the discount to NTA.

The Antipodes Global Investment Company pursued a range of NTA discount control mechanisms including the largest on-market LIC share buy-back in ASX history. This failed to work.

Antipodes Global Investment Company is now trying a tender offer program that will enable shareholders to exit a minimum of 25 per cent of their shareholding at close to NTA.

 

 

This article originally appeared in the Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

 

 

LICs appeal to Australian investors wanting reliable fully franked dividends. But many traded at a discount to net tangible assets which has prompted widespread rationalisation.

The $50 billion listed investment company sector is a hotbed of consolidation as one big player and smaller groups of shareholder activists crank up the pressure on boards to close the widespread discounts to net tangible assets.

Proof that the strong are getting stronger and the weak disappearing came on Monday when the Australian Leaders Fund said it would allow shareholders to switch to an unlisted unit trust offering redemptions at NTA and entities managed by Wilson Asset Management made a takeover bid for the Contango Income Generator.

Industry veterans say the level of activity around the efforts to close the discounts to NTA are the most intense the market has seen since a wave of consolidation occurred in 2003 and 2004.

Discounts to NTA have been a feature of the LIC sector for decades and many different methods have been used to close the discount. The discounts can blow out to 25 per cent or higher. Some LICs have had their share prices stuck at 10 per cent discounts to NTA for years.

This rightly causes angst among shareholders, especially those who joined an LIC at the time of its float and then watched their investment sink in value on the sharemarket. Their plight is made less palatable when they see other LICs trading at premiums to NTA.

It may not be fair but poor performance in the sharemarket often has nothing to do with the movement in NTA, which can rise because of good funds management decisions and then not be reflected in the share price.

It would seem LIC investors are great believers in this structure for getting access to franked dividends. Chanticleer understands that up to a third of the individuals on the share registers of some prominent LICs are also owners of rival LICs. This plays into the hands of consolidators like Geoff Wilson at WAM.

 

Shareholder action

LICs trading at a premium to NTA include Australian Foundation Investment Company, Argo Investments and five of the six LICs in the WAM stable. They owe their premium status to their consistent and growing dividend payment policies.

Poor performers in the sector are increasingly finding themselves the subject of corporate action or agitation by shareholders concerned about entrenched practices that foster lack of transparency and accountability.

Two veterans of the finance sector, Malcolm McComas and Rob Ferguson, dipped their toes in the LIC consolidation pool this year with a successful agitation campaign against the board of ALF for its discount to NTA.

They claimed the manager of ALF, Justin Braitling's Watermark Funds Management, was responsible for poor sharemarket performance and action was needed. Their attack on ALF's failure to address its discount to NTA included criticism of Wilson, who is the most active player in terms of rationalising LICs.

In a letter to ALF shareholders, McComas and Ferguson said "the board of ALF has had a wake-up call on its terrible past governance and finally decided to appoint an independent board committee composed of directors John Abernethy and Julian Gosse to consider appropriate capital management strategies to recommend to all shareholders".

"The appointment of this committee in response to our agitation is highly significant," Ferguson and McComas said.

"First it is clear recognition that our chairman Justin Braitling and his fellow director Geoff Wilson are not independent and should absent themselves from any board matters where they have a conflict of interest.

"It is likely that any “capital management strategies” will reduce the size of the company materially and therefore materially reduce the fees paid to Justin Braitling’s company Watermark Funds Management. WFM shares such fees with an entity associated with Geoff Wilson and thus their conflicts of interest arise and mean they cannot vote on such matters."

 

Experimental techniques

Wilson tells Chanticleer the ALF funds management contract is with Watermark and not him. Also, he questioned the corporate performances of McComas and Ferguson.

Ferguson says Abernethy did a good job negotiating a termination of Watermark's funds management agreement at a price of $2.5 million or 1.25 per cent of NTA. This contract had another seven years to run.

The nearest comparable deal was the termination of the Ellerston Capital funds management contract with Ellerston Global Investments.

McComas says the ALF solution to its discount to NTA problem is not fair to shareholders because if you redeem your shares within the first year there is a fee of 2 per cent.

Abernethy says contractual agreements cannot be unwound easily. He says it is possible shareholders who stay with the ALF entity for more than a year could achieve an internal rate of return of 7 per cent assuming redemption after the period when the 2 per cent fee requirement has expired.

Wilson is being highly proactive in reduced discounts to NTA with other LICs. The WAM Capital bid for Contango Income Generator is a share swap deal that values each share at a 74¢, which is either equal to NTA or a premium.

At the same time, Wilson has a takeover bid for the Concentrated Leaders Fund which involves a WAM Capital share swap that values each share at about $1.18, a premium to NTA.

Other LICs trading at a discount are experimenting with new techniques for closing the discount to NTA.

The Antipodes Global Investment Company pursued a range of NTA discount control mechanisms including the largest on-market LIC share buy-back in ASX history. This failed to work.

Antipodes Global Investment Company is now trying a tender offer program that will enable shareholders to exit a minimum of 25 per cent of their shareholding at close to NTA.

 

 

This article originally appeared in the Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

 

 

Disclaimer: This material has been prepared by Australian Financial Review, published on Sep 29, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.